on NEOVACS (EPA:ALNEV)
NEOVACS: Amendment to the trust agreement to optimize financing
On March 25, 2025, Neovacs announced an amendment to its trust agreement established in June 2023. This change aims to improve the terms of subscription to the straight bonds (SBDs) for optimized financing. The trust, initially created to convert and transfer the SBDs, has had its term extended to 2027 and its terms adjusted.
The outstanding ORAs will be replaced by SOs on March 31, 2025, allowing the trust to fund Neovacs through SO issuances at defined intervals. Amendments to the terms of the SOs are also planned to extend the funding period.
Warning: Investors should remain cautious as these dilutive financings could reduce the value of the shares and result in significant capital dilution.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NEOVACS news